We are live on ! Find out more
NHAS

Novo Holdings A/S Portfolio holdings

AUM $1.23B
1-Year Est. Return 81.32%
This Fund
S&P 500
This Quarter Est. Return
+17.59%
1 Year Est. Return
+81.32%
3 Year Est. Return
+192.63%
5 Year Est. Return
+125.03%
10 Year Est. Return
+943.65%
AUM
$1.29B
AUM Growth
-$264M
Cap. Flow
-$418M
Cap. Flow %
-32.48%
Top 10 Hldgs %
71.3%
Holding
28
New
1
Increased
3
Reduced
3
Closed
4

Top Buys

Rank Stock Value
1
MPLT
MapLight Therapeutics
MPLT
+$61.8M
2
FDMT icon
4D Molecular Therapeutics
FDMT
+$16.7M
3
APGE icon
Apogee Therapeutics
APGE
+$4.41M
4
ELVN icon
Enliven Therapeutics
ELVN
+$1.07M

Top Sells

Rank Stock Value
1
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$341M
2
MRUS
Merus
MRUS
+$70.6M
3
RXRX icon
Recursion Pharmaceuticals
RXRX
+$38.7M
4
ASML icon
ASML
ASML
+$33.3M
5
ZBIO
Zenas BioPharma
ZBIO
+$18.1M

Sector Composition

Rank Sector Weight
1 Healthcare 68.02%
2 Technology 16.42%
3 Financials 12.46%
4 Consumer Discretionary 2.93%
5 Industrials 0.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRUS
26
DELISTED
Merus
MRUS
– –
-750,000
Closed -$70.6M
RXRX icon
27
Recursion Pharmaceuticals
RXRX
$1.73B
– –
-7,929,835
Closed -$38.7M
VTI icon
28
Vanguard Morningstar Total Stock Market ETF
VTI
$684B
– –
-1,038,550
Closed -$341M
1
2

Similar funds

MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
FLII
First Long Island Investors Jericho, New York $1.23B AUM 14.42% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
IA
Inspire Advisors Meridian, Idaho $1.23B AUM 18.62% 1-Year Est. Return
HTHT
Hemenway Trust Hemenway Trust Salem, New Hampshire $1.24B AUM 16.52% 1-Year Est. Return
BCP
BlackBarn Capital Partners New York $1.24B AUM 55.98% 1-Year Est. Return
SPC
Stony Point Capital New York $1.24B AUM 32.69% 1-Year Est. Return
SC
Strategy Capital Los Altos, California $1.22B AUM 27.02% 1-Year Est. Return

Novo Holdings A/S's Q4 2025 Portfolio in Review

As of Q4 2025, Novo Holdings A/S held 28 positions worth $1.29B, down 17% from $1.55B the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Novo Holdings A/S withdrew a net $418M in Q4 2025, closing 4 positions and reducing 3 holdings. Its most notable exit was Vanguard Morningstar Total Stock Market ETF, an estimated $341M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 68% of assets, up from 50% a quarter earlier, followed by Technology and Financials.

Against the trend, Novo Holdings A/S opened a new position in MapLight Therapeutics worth $64.8M.

  • Novo Holdings A/S's largest Q4 2025 buy was MapLight Therapeutics: 3,686,622 shares worth $64.8M.
  • Novo Holdings A/S added most to 4D Molecular Therapeutics in Q4 2025, an estimated $16.7M increase.
  • Novo Holdings A/S's biggest Q4 2025 reduction was ASML, cutting an estimated $33.3M.
  • Novo Holdings A/S fully exited Vanguard Morningstar Total Stock Market ETF in Q4 2025, selling an estimated $341M.
  • Novo Holdings A/S's ten largest holdings make up 71% of its $1.29B portfolio in Q4 2025.
  • Novo Holdings A/S opened 1 new position and closed 4 in Q4 2025.
  • Novo Holdings A/S's portfolio value fell 17% quarter-over-quarter to $1.29B.

Based on Novo Holdings A/S's 13F filing for Q4 2025, filed 17 Feb 2026.